Back to Directory
Avata Biosciences
Founded 2022
Synthetic cannabinoid medicines for neurological diseases
Avata Biosciences is a pharmaceutical company developing synthetic cannabinoid medicines for neurological and psychiatric conditions. Its formulation technology converts poorly water-soluble cannabidiol into preparations suitable for capsules and aqueous solutions. The company’s pipeline targets adult and paediatric focal epilepsy and schizophrenia. Formerly known as Sapient Therapeutics, Avata focuses on prescription drug development using synthetic cannabinoids and proprietary formulation methods.
Company Notes
Previously Known As
Sapient Therapeutics